Human Papillomavirus (HPV) Testing Market Research Report
The global human papillomavirus (HPV) testing market size is anticipated to rise from US$ 1,400 Mn in 2025 to US$ 2,816.3 Mn by 2032. It is projected to witness a CAGR of 10.5% from 2025 to 2032.
Human papillomavirus (HPV) testing is a diagnostic procedure used to detect the presence of high-risk HPV strains that can lead to cervical cancer and other HPV-related diseases. The demand for HPV tests globally is experiencing an uptick on account of the increasing cases of cancer and mortality. According to the American Cancer Society, in 2025, approximately 2,041,910 new cancer cases and 618,120 cancer deaths are estimated to occur in the U.S.